Pages that link to "Q34998010"
Jump to navigation
Jump to search
The following pages link to Prostaglandin catabolizing enzymes (Q34998010):
Displaying 50 items.
- High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships (Q21136072) (← links)
- Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2 (Q24313365) (← links)
- 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers (Q24318523) (← links)
- Regulation of immune responses by prostaglandin E2 (Q26849305) (← links)
- COX-2 and PGE2-dependent immunomodulation in breast cancer (Q27003937) (← links)
- Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂ (Q27008521) (← links)
- Prostaglandins and cancer (Q28188827) (← links)
- Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid (Q28252674) (← links)
- Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy (Q28281228) (← links)
- The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor (Q28298968) (← links)
- Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity (Q28509544) (← links)
- Involvement of the constitutive prostaglandin E synthase cPGES/p23 in expression of an initial prostaglandin E2 inactivating enzyme, 15-PGDH (Q28570316) (← links)
- 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer (Q28592082) (← links)
- Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit (Q30573518) (← links)
- Inhibition of immune responses and related proteins in Rhamdia quelen exposed to diclofenac. (Q31155555) (← links)
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms (Q33581564) (← links)
- In-vitro Wound Healing Effect of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor from Plant (Q33609153) (← links)
- Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. (Q33685598) (← links)
- Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo (Q33759512) (← links)
- Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1/2 signalling (Q33929749) (← links)
- Metabolism and Ocular Tissue Distribution of an Antiglaucoma Prostanoid, Tafluprost, After Ocular Instillation to Monkeys (Q34178298) (← links)
- Crucial role of macrophage selenoproteins in experimental colitis (Q34218777) (← links)
- Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation (Q34226575) (← links)
- Analysis of lead toxicity in human cells (Q34354516) (← links)
- 15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways (Q34450882) (← links)
- Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun (Q34462544) (← links)
- Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? (Q34494513) (← links)
- Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology (Q34952213) (← links)
- 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis (Q35033202) (← links)
- 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids (Q35126717) (← links)
- Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development (Q35138248) (← links)
- Giant ectopic liver, hepatocellular carcinoma and pachydermia-a rare genetic syndrome? (Q35183254) (← links)
- The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache (Q35214562) (← links)
- Resolvins and protectins in inflammation resolution. (Q35332873) (← links)
- Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice (Q35552440) (← links)
- Hematopoietic prostaglandin D synthase (HPGDS): A high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer (Q35581048) (← links)
- Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment (Q35581635) (← links)
- Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm (Q35749972) (← links)
- Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice (Q35870151) (← links)
- 15-hydroxyprostaglandin dehydrogenase is upregulated by hydroxychloroquine in rheumatoid arthritis fibroblast-like synoviocytes (Q35919681) (← links)
- Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer (Q35929848) (← links)
- Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells (Q36099516) (← links)
- Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat (Q36179560) (← links)
- Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue (Q36246027) (← links)
- MicroRNA and AU-rich element regulation of prostaglandin synthesis (Q36249379) (← links)
- Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent (Q36335519) (← links)
- Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice. (Q36372631) (← links)
- Intestinal smooth muscle dysfunction develops postnatally in cystic fibrosis mice (Q36418541) (← links)
- Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis (Q36459962) (← links)
- Prostaglandin E2 receptor distribution and function in the gastrointestinal tract (Q36611067) (← links)